The following is a summary of “Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with ...

The following is a summary of “Physiologic Pulmonary Phenotyping of Infants Born Preterm and Post-Discharge Respiratory ...

Children diagnosed with interstitial lung disease often survive into adulthood, when they are likely to need care for related impairments.

Chemotherapy for lung cancer is used for different purposes depending on the type and stage of cancer you have. This includes achieving cancer remission, shrinking a tumor before surgery, killing ...

In COPD, the lung may express even greater variability, since the airways may be affected even more than the parenchyma. Emphysema is patchy at the same time, while the airways and local areas in ...

Nerandomilast is under clinical development by Boehringer Ingelheim International and currently in Phase III for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). According to GlobalData, ...

Lung cancer liver metastases are tumors that form in the liver from cancer cells that have broken away from the primary cancer and spread through the blood or lymphatic system. The liver is a common ...

In some cases, you may have lung granulomas that show no abnormal signs. They don’t usually need treatment or other testing. Granulomas are usually found during a doctor’s visit for something ...

The iron lung, conceptualized in the late 1920s, was most notably the first line of defense against polio during the epidemics that occurred between 1948 to 1955. The device saved the lives of ...

ILD: Interstitial lung disease. Proteomics targets the elucidation of the disease mechanisms and detection of new biomarkers for early diagnosis and/or differential diagnosis of a specific disease.

A lung biopsy involves the removal of tissue or growths from the lungs. A doctor will use special devices, such as a fine needle, to remove the sample. A lung biopsy can help diagnose lung ...

Olokizumab is under clinical development by R-Pharm and currently in Phase III for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). According to GlobalData, Phase III drugs for ...